FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
Article in Cureus (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Cureus (May 2024)
Article in Health Expectations (April 2024)
Article in RMD Open (January 2024)